Phase 1 Inflammatory Response Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Double-blind Pilot Study on the Effect of Anionic Exposome Enrichment (Biow) on Recovery and Sleep Quality in Postoperative Patients

Postoperative RecoveryInflammatory Response After Surgery

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz150 enrolled1 locationNCT06968000

Recruiting

Phase 1Phase 2

Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 and/or Acute Respiratory Distress Syndrome (THYTECH2)

Systemic Inflammatory Response Syndrome

Hospital General Universitario Gregorio Marañon24 enrolled1 locationNCT06052436